Clinical factors associated with hepatitis B screening and vaccination in high-risk adults

Table 5 Gastrointestinal history and healthcare utilization

	Screening cohort			Vaccination cohort
Variate	Screened for HBV (n = 556)	Not screened for HBV (n = 443)	P-value	Vaccinated against HBV (n = 242)	Not vaccinated against HBV (n = 314)	P-value
HCV serology	82.4%	19.2%	< 0.001	78.5%	85.4%	0.047
HCV infection	9.4%	11.5%	0.312	12.1%	10.2%	0.629
Hepatitis A vaccination	36.0%	0%	< 0.001	51.7%	23.9%	< 0.001
Hepatitis A (HAVab IgM or IgG)	26.1%	4.3%	0.002	27.9%	24.7%	0.616
1 or more primary care visit per year	43.8%	30.9%	< 0.001	38.1%	48.1%	0.030
1 or more emergency department visit per year	56.6%	26.7%	< 0.001	57.0%	56.4%	0.956
1 or more gastroenterology visit per year	35.4%	19.4%	< 0.001	31.9%	38.0%	0.166
MELD score (median; 25-75th percentile)	16 (11-23)	12 (8-20)	0.019	16 (11-22)	17 (12-24)	0.586
All-cause mortality	11.3%	2.7%	< 0.001	10.7%	11.8%	0.804
Liver-related mortality	2.0%	0.5%	0.067	2.4%	1.6%	0.662
Listed for liver-transplant	8.1%	5.6%	0.167	6.6%	9.2%	0.333

MELD: Model for end-stage liver disease.